Abnet CC, Arnold M, Wei WQ (2018) Epidemiology of esophageal squamous cell carcinoma. Gastroenterology 154:360–373. https://doi.org/10.1053/j.gastro.2017.08.023

Article  PubMed  Google Scholar 

Yu J, Ouyang W, Li Y, Hu J, Xu Y, Wei Y, Liao Z, Liu Y, Zhang J, Xie C (2019) Value of radiotherapy in addition to esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma: analysis of surveillance, epidemiology, and end results database. Cancer Med 8:21–27. https://doi.org/10.1002/cam4.1731

Article  PubMed  Google Scholar 

Gao Y, Guan L, Jia R, Xiao W, Han Y, Li Y, Tang P, Yu Z, Zhang H (2023) High expression of PPFIA1 in human esophageal squamous cell carcinoma correlates with tumor metastasis and poor prognosis. BMC Cancer 23:417. https://doi.org/10.1186/s12885-023-10872-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Obata Y, Kanda M, Shimizu D, Takami H, Inokawa Y, Hattori N, Hayashi M, Tanaka C, Nakayama G, Kodera Y (2023) The preoperative systemic immune-inflammation index is associated with an unfavorable prognosis for patients undergoing curative resection of esophageal squamous cell carcinoma after neoadjuvant therapy. Surg Today 53:964–972. https://doi.org/10.1007/s00595-023-02658-0

Article  CAS  PubMed  Google Scholar 

Xiao W, Tang P, Sui Z, Han Y, Zhao G, Wu X, Yang Y, Zhu N, Gong L, Yu Z, Zhang H (2023) Establishment of a risk model by integrating hypoxia genes in predicting prognosis of esophageal squamous cell carcinoma. Cancer Med 12:2117–2133. https://doi.org/10.1002/cam4.5002

Article  CAS  PubMed  Google Scholar 

Bai CY, Zhang JY, Shi TW, Bai YQ, Wu BL, Du ZP, Wu ZY, Xu XE, Wang SH, Wu JY, Te RY, Zhang JY, Xu LY, Li EM (2018) Association between 5‑lipoxygenase expression, and malignant behaviors and poor prognosis in esophageal squamous cell carcinoma. Oncol Lett 15:9353–9360. https://doi.org/10.3892/ol.2018.8527

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bao J, Zhou C, Zhang J, Mo J, Ye Q, He J, Diao J (2018) Upregulation of the long noncoding RNA FOXD2-AS1 predicts poor prognosis in esophageal squamous cell carcinoma. Cancer Biomark 21:527–533. https://doi.org/10.3233/CBM-170260

Article  CAS  PubMed  Google Scholar 

Cao T, Shen J, Pan W, Li C, Qiao Z (2018) Upregulation of long noncoding RNA ANRIL correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma. J Buon 23:1862–1866

PubMed  Google Scholar 

Wu X, Zhang H, Chen C, Gong L, Wang Y, Zhu X, Wang H, Yu Z (2018) High expression of capn4 is associated with metastasis and poor prognosis in esophageal squamous cell carcinoma. Int J Clin Exp Pathol 11:765–772

PubMed  PubMed Central  Google Scholar 

Liang H, Fan JH, Qiao YL (2017) Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China. Cancer Biol Med 14:33–41. https://doi.org/10.20892/j.issn.2095-3941.2016.0093

Article  PubMed  PubMed Central  Google Scholar 

Conway E, Wu H, Tian L (2023) Overview of risk factors for esophageal squamous cell carcinoma in China. Cancers. https://doi.org/10.3390/cancers15235604

Article  PubMed  PubMed Central  Google Scholar 

Xue X, Sun Q, Jiang D, Wang X, Liu Y, Guo C, Liu L, Cheng N, Wang G, Liu Y, Hou Y, Fan X, Xue L (2023) The efficacy of additional surgical resection after endoscopic resection in pT1b esophageal squamous cell carcinoma: a multi-institutional retrospective study in China. Surg Endosc 37:871–880. https://doi.org/10.1007/s00464-022-09459-5

Article  PubMed  Google Scholar 

Zhou C, Wei J, Xu K, Lin Y, Zhang L, Li X (2023) Cost-effectiveness analysis of tislelizumab plus chemotherapy as first-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China. RMHP 16:2447–2458. https://doi.org/10.2147/RMHP.S436750

Article  Google Scholar 

Zhong L, Li H, Chang W, Ao Y, Wen Z, Chen Y (2023) TP53 mutations in esophageal squamous cell carcinoma. Front Biosci 28:219. https://doi.org/10.31083/j.fbl2809219

Article  CAS  Google Scholar 

Jin Y, Zhao X, Song X, Wang R, Fan Z, Wang P, Yang M, Zhou F, Bao Q, Wang L (2023) The high expression of p53 is predictive of poor survival rather TP53 mutation in esophageal squamous cell carcinoma. J Oncol 2023:3801526. https://doi.org/10.1155/2023/3801526

Article  CAS  PubMed  PubMed Central  Google Scholar 

Niyaz M, Ainiwaer J, Abudureheman A, Zhang L, Sheyhidin I, Turhong A, Cai R, Hou Z, Awut E (2020) Association between TP53 gene deletion and protein expression in esophageal squamous cell carcinoma and its prognostic significance. Oncol Lett 20:1855–1865. https://doi.org/10.3892/ol.2020.11709

Article  CAS  PubMed  PubMed Central  Google Scholar 

He W, Gong S, Wang X, Dong X, Cheng H (2021) DNA methylation integratedly modulates the expression of Pit-Oct-Unt transcription factors in esophageal squamous cell carcinoma. J Cancer 12:1634–1643. https://doi.org/10.7150/jca.49231

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang L, Liou YL, Wan ZR, Tang J, Zhou Y, Zhuang W, Wang G (2019) Aberrant DNA methylation of PAX1, SOX1 and ZNF582 genes as potential biomarkers for esophageal squamous cell carcinoma. Biomed Pharmacother 120:109488. https://doi.org/10.1016/j.biopha.2019.109488

Article  CAS  PubMed  Google Scholar 

Wang J, Sasco AJ, Fu C, Xue H, Guo G, Hua Z, Zhou Q, Jiang Q, Xu B (2008) Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 17:118–125. https://doi.org/10.1158/1055-9965.EPI-07-0733

Article  CAS  PubMed  Google Scholar 

Kaimila B, Mulima G, Kajombo C, Salima A, Nietschke P, Pritchett N, Chen Y, Murphy G, Dawsey SM, Gopal S, Phiri KS, Abnet CC (2022) Tobacco and other risk factors for esophageal squamous cell carcinoma in lilongwe malawi: results from the lilongwe esophageal cancer case: control study. PLOS Glob Public Health 2:e135. https://doi.org/10.1371/journal.pgph.0000135

Article  PubMed  PubMed Central  Google Scholar 

Wang JM, Xu B, Rao JY, Shen HB, Xue HC, Jiang QW (2007) Diet habits, alcohol drinking, tobacco smoking, green tea drinking, and the risk of esophageal squamous cell carcinoma in the chinese population. Eur J Gastroenterol Hepatol 19:171–176. https://doi.org/10.1097/MEG.0b013e32800ff77a

Article  CAS  PubMed  Google Scholar 

Wu CF, Wu DC, Hsu HK, Kao EL, Lee JM, Lin CC, Wu MT (2005) Relationship between genetic polymorphisms of alcohol and aldehyde dehydrogenases and esophageal squamous cell carcinoma risk in males. WJG 11:5103–5108. https://doi.org/10.3748/wjg.v11.i33.5103

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yokoyama T, Yokoyama A, Kato H, Tsujinaka T, Muto M, Omori T, Haneda T, Kumagai Y, Igaki H, Yokoyama M, Watanabe H, Yoshimizu H (2003) Alcohol flushing, alcohol and aldehyde dehydrogenase genotypes, and risk for esophageal squamous cell carcinoma in Japanese men. Cancer Epidemiol Biomarkers Prev 12:1227–1233

CAS  PubMed  Google Scholar 

Ding X, Barodia SK, Ma L, Goldberg MS (2017) Fbxl18 targets LRRK2 for proteasomal degradation and attenuates cell toxicity. Neurobiol Dis 98:122–136. https://doi.org/10.1016/j.nbd.2016.11.004

Article  CAS  PubMed  Google Scholar 

Liu Y, Lear T, Zhao Y, Zhao J, Zou C, Chen BB, Mallampalli RK (2015) F‑box protein Fbxl18 mediates polyubiquitylation and proteasomal degradation of the pro-apoptotic SCF subunit Fbxl7. Cell Death Dis 6:e1630. https://doi.org/10.1038/cddis.2014.585

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang W, Lu Y, Wang F, Huang X, Yu Z (2020) Circular RNA circRNA_103809 accelerates bladder cancer progression and enhances chemo-resistance by activation of miR-516a-5p/FBXL18 axis. CMAR 12:7561–7568. https://doi.org/10.2147/CMAR.S263083

Article  CAS  Google Scholar 

Chiu HW, Chang JS, Lin HY, Lee HH, Kuei CH, Lin CH, Huang HM, Lin YF (2018) FBXL7 Upregulation predicts a poor prognosis and associates with a possible mechanism for paclitaxel resistance in ovarian cancer. J Clin Med. https://doi.org/10.3390/jcm7100330

Article  PubMed  PubMed Central